Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.


Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Our services at a glance

Discovery Services

Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.

Development and Manufacturing services

Syngene’s offers an end-to-end platform to deliver integrated and standalone services for small molecules across the Development continuum.

Service Brochures

SynSight: Syngene’s data Consortium

Syngene’s data consortium comprises a group of consenting clients working towards greater learning through predictive modeling to enable faster drug discovery.

Holistic Target Identification and Validation services

Syngene’s Target Identification and Validation services combine data, informatics, and knowledge about biological target assays for holistic target assessment and risk mitigation in drug discovery.

ADME/PK profiling capabilities

Syngene, with its comprehensive suite of DMPK profiling assays, can help you achieve a high rate of success with your clinical candidates across drug modalities.

Chemistry process research lab for Drug Discovery

Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.

Safety Assessment services

Syngene offers the full range of IND-enabling Exploratory and GLP Tox studies for small molecules and biologics.

Chemical Development services

Syngene offers complete value-chain process research and development services across novel chemical entities, APIs, and advanced intermediates – route-scouting to commercial manufacturing.

Formulation Development services: Stable and compliant drug formulations across oral solids and parenterals

Syngene offers Formulation Development services for oral solids, liquids, and injectable forms, including integrated services focusing on quality, speed, and cost-efficiency.

Sterile Fill-Finish facility: Your integrated partner for customized clinical supplies

Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for clinical supply of sterile drug products having short development timelines.

Analytical Development services – IND Filing to Commercial

Syngene has one of the largest Analytical facilities in Asia. The facility supports small molecules and biologics programs from early development to CMC filing and commercialization.

Nitrosamine Impurity Testing Services

Syngene’s Center of Excellence for Nitrosamine impurity testing supports formulation requirements for small molecule APIs, key sourcing materials, and intermediates.

ICH Stability services

One of the largest Stability facilities in Asia, Syngene supports both small molecules and biologics from early development to CMC 

Your one-stop solution for Biologics: Target to Therapy

Syngene offers end-to-end Biologics Development and Manufacturing solutions for mammalian and microbial systems, including Viral Testing and Sterile Fill-Finish. We also have the expertise to move from Gene to GMP in 10 months.

Animal Health Services: Enabling safe, cost-effective products – molecule to market
Syngene offers an entire ecosystem of service offerings for Animal Health, ranging from discovery to manufacturing.
End-to-End PROTAC solutions: Early proof-of-concept to Formulation

Syngene offers end-to-end and integrated solutions for PROTACs ranging from early proof-of-concept studies to identifying a development candidate.

Oligonucleotides services

Syngene’s services encompass therapeutic oligonucleotides, diagnostic oligonucleotides, enzymatic synthesis, and analytical services.

Building resilience in Supply Chain Management – the Syngene way

Syngene has a well-defined system that delivers across all aspects of Supply Chain Management, ranging from planning and inventory to sourcing, procurement, logistics, performance, safety, and compliance.

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details